In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Hold rating on Sanofi (SNYNF – Research Report), with a price ...

Four years after Sanofi shelled out $125 million for global rights to Biond Biologic | The company is handing back the tumor ...

Vivitein BLG is a dairy protein (beta-lactoglobulin) which is produced through precision fermentation, with no animals ...

Immunology is a rapidly advancing field with significant potential for growth, especially in the realm of biotech and pharmaceutical companies.

DelveInsight's High Potency Active Pharmaceutical Ingredients Market Insights report provides the current and forecast market ...

SOUTH SAN FRANCISCO, Calif., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) reported a ...

Polaryx Logo PARAMUS, NJ, UNITED STATES, February 26, 2025 /EINPresswire / -- Polaryx Therapeutics , a late-stage clinical biotech company dev ...

The expansion of the advanced therapy medicinal products market is primarily fueled by the increasing incidence of chronic diseases. The rising prevalence of genetic disorders and cancer, along ...

The growing global prevalence of influenza, mainly due to the transmission of the virus through droplets from coughing and sneezing, is the primary driver for the need for influenza vaccination.

The FDA granted orphan designation to Sanofi ( SNY) US Services’ rilzabrutinib as a treatment of autoimmune hemolytic anemia, according to a post to the agency’s website. Published first on TheFly – ...

Sanofi and CD&R have signed a share purchase agreement for the sale of a 50% stake in the consumer health business.

The future is upon us, and it's asking more from us as designers. AI and Logo Design: Friend or Foe? Artificial Intelligence is making waves in the design world, with logo design being no exception.